DIG
ACIU icon

Dauntless Investment Group’s AC Immune ACIU Stock Holding History

Dauntless Investment Group’s Portfolio ACIU Stock Details ACIU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$296K Sell
107,489
-8,188
-7% -$25.4K 0.2% 41
2025
Q4 		$363K Buy
+115,677
New +$365K 0.29% 40

Other funds holding ACIU

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Dauntless Investment Group's ACIU Position: Q1 2026 in Review

Dauntless Investment Group reduced its AC Immune (ACIU) stake by 7.1% in Q1 2026, selling an estimated $25.4K and leaving 107,489 shares worth $296K. The position accounts for 0.2% of the portfolio, ranked #41.

Dauntless Investment Group first reported a position in ACIU in Q4 2025 and has held it in 2 quarters since. The position peaked at $363K in Q4 2025. 46 funds tracked by Wall St. Rank hold ACIU as of Q1 2026.

  • Dauntless Investment Group held 107,489 shares of AC Immune worth $296K as of Q1 2026.
  • Dauntless Investment Group sold 8,188 AC Immune shares in Q1 2026, an estimated $25.4K.
  • AC Immune made up 0.2% of Dauntless Investment Group's portfolio in Q1 2026, its #41 holding.
  • Dauntless Investment Group first reported a position in AC Immune in Q4 2025 and has held it in 2 quarters since.
  • Dauntless Investment Group's AC Immune position peaked at $363K in Q4 2025.
  • 46 funds tracked by Wall St. Rank held AC Immune as of Q1 2026.

Based on Dauntless Investment Group's 13F filing for Q1 2026, filed 14 May 2026.